A possible workaround came from a team led by Ernie Blevins of the University of Washington. They gave obese rats a low dose ...

How it began: When Valley Plaza opened in 1951, it was right when the shopping experience was changing. The developer behind ...

Bravo TV host Andy Cohen told the TODAY show that microdosing a GLP-1 drug helped him lose “a good chunk of weight.” The ...

Diabetes is not just a disease; it’s a warning sign that your system is off course. You can’t change your genes, but you can ...

Online stores offer injectable vials for $300 to $600 each. But many of the products have never been extensively studied in ...

TAMPA, FL / ACCESS Newswire / November 20, 2025 / (“Wellgistics”) (NASDAQ:WGRX), a health information technology leader at the nexus of serialization of healthcare technology infrastructure into the ...

U.S. consumers who have had their fill of finding protein added to everything from cereal to ice cream are about to meet the ...

New research is shedding light on how weight-loss and diabetes medications like Ozempic, Wegovy, and Mounjaro affect not only ...

For those with decades left in their investing journey, these top healthcare stocks could be worthy portfolio contenders.

New GLP-1 weight-loss drugs may preserve muscle, protect skin, and reduce the risk of "Ozempic face." Experts explain what ...

A new meta-analysis of 31 preclinical studies suggests GLP-1 drugs like semaglutide may reduce ischemic stroke severity in ...

By 2030, households with GLP-1 users are projected to represent 35% of all food and beverage units sold, the consumer ...